80 likes | 89 Views
According to The Insight Partners market research study of u201cNucleic Acid Amplification, Detection, and Diagnostics Market Forecast to 2027 u2013 COVID-19 Impact and Global Analysis u2013 by Nucleic Acid, Process, Product Type, Technology, Application, End User, and Geographyu201d, the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019. The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027. The report highlights trends prevailing in the global nucleic acid amplification, detection, and dia
E N D
Nucleic Acid Amplification Detection and Diagnostics Market Global Analysis and Forecast to 2028 Published Date : Nov 2020 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Nucleic Acid Amplification Detection and Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Nucleic Acid (Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)); Process (Amplification, Detection, Diagnostics); Product Type (Assays, Kits and Reagents, Systems); Technology (Polymerase Chain Reaction (PCR), Isothermal Amplification Technology, Direct Nucleic Acid Detection, Next Generation Sequencing (NGS), CRISPR-Cas9); Application (Infectious Diseases, Genetic Diseases, Forensic Testing, Paternity Testing, Oncology, Others); End User (Hospital and Clinics, Diagnostic Centers, Research Institutes, Others), and Geography 2
Email: sales@theinsightpartners.com Nucleic Acid Amplification Detection and Diagnostics Market Overview The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% from 2020 to 2027. Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning. Extensively increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems. The nucleic acid amplification, detection, and diagnostics market is expected to witness a significant growth due to increasing prevalence of infectious diseases and rising demand for advanced diagnostic systems. However, lack of adequate infrastructure in emerging countries is estimated to hamper the growth of the market during the forecast period. 3
Email: sales@theinsightpartners.com Key Segment Market Segment By Type:- By Product Type (Assays, Kits and Reagents, Systems) Application (Infectious Diseases, Genetic Diseases, Forensic Testing, Paternity Testing, Oncology, Others) End-User (Hospital and Clinics, Diagnostic Centers, Research Institutes, Others) Download Sample Here 4
Email: sales@theinsightpartners.com Nucleic Acid Amplification Detection and Diagnostics Market Value $50,000 $40,000 $30,000 CAGR of 13.4% $20,000 (2020 – 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles BD bioMerieux SA BIO-RAD LABORATORIES INC. THERMO FISHER SCIENTIFIC INC. Illumina, Inc. Danaher QIAGEN Abbott Meridian Bioscience, Inc. F. Hoffmann-La Roche Ltd. Download Sample Here 6
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com